Cabral Gold Inc.
Cabral Gold Inc. (CBR.V) Financial Performance & Income Statement Overview
Analyze Cabral Gold Inc. (CBR.V) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Cabral Gold Inc. (CBR.V) Income Statement & Financial Overview
View the income breakdown for Cabral Gold Inc. CBR.V across both annual and quarterly reports.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Cost of Revenue | $136485.00 | $134000.00 | $137519.00 | $170427.00 |
Gross Profit | -$136485.00 | -$134000.00 | -$137519.00 | -$170427.00 |
Gross Profit Ratio | ||||
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.42M | $252182.00 | $221706.00 | $1.54M |
Operating Expenses | $1.42M | $1.99M | $1.73M | $1.54M |
Total Costs & Expenses | -$1.56M | $2.12M | $1.87M | $1.71M |
Interest Income | $8292.00 | $6361.00 | $31554.00 | $35380.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $136485.00 | $134000.00 | $137519.00 | $170427.00 |
EBITDA | -$1.46M | -$2.11M | -$1.73M | -$1.39M |
EBITDA Ratio | ||||
Operating Income | -$1.56M | -$2.12M | -$1.87M | -$1.71M |
Operating Income Ratio | ||||
Other Income/Expenses (Net) | -$37583.00 | -$118108.00 | -$3247.00 | $147313.00 |
Income Before Tax | -$1.60M | -$2.24M | -$1.87M | -$1.56M |
Income Before Tax Ratio | ||||
Income Tax Expense | $0.00 | $0.00 | $0.00 | $3.00 |
Net Income | -$1.60M | -$2.24M | -$1.87M | -$1.56M |
Net Income Ratio | ||||
EPS | -$0.007 | -$0.01 | -$0.009 | -$0.008 |
Diluted EPS | -$0.007 | -$0.01 | -$0.009 | -$0.008 |
Weighted Avg Shares Outstanding | $214.61M | $204.17M | $199.85M | $188.18M |
Weighted Avg Shares Outstanding (Diluted) | $214.61M | $204.17M | $199.85M | $188.18M |
Over the past four quarters, Cabral Gold Inc. demonstrated steady revenue growth, increasing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Operating income reached -$1.56M in Q4 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$1.46M, reflecting operational efficiency. Net income rose to -$1.60M, with EPS at -$0.007. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan